secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001140361-23-029854
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 1.02, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics sells dialysis & biopsy product portfolio to Merit Medical for $100M cash
--------------------------------------------------------------------------------

- Closed June 8, 2023; proceeds used to repay ~$49.8M in debt under credit agreement, terminating it.
- Estimated net cash proceeds of $46.8M after transaction costs and debt payoff.
- Sold business contributed $23.7M revenue (9mo Feb 2023) and $27.7M (FY2022); pro forma operating loss increased ~$12.7M and ~$14.9M.
- Company entered transition services and contract manufacturing agreements; five-year non-compete on sold business.
- Pro forma balance sheet shows cash rising to $76.9M and long-term debt eliminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000114036123029854/0001140361-23-029854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000114036123029854/brhc20054314_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-029854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer